FIELD: medicine, dermatology. SUBSTANCE: invention proposes etaden as an antiherpetic agent. Preparation shows an antiviral activity. EFFECT: valuable antiviral properties. 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING INDICATIONS FOR INTERFERONOTHERAPY IN CASE OF OPHTHALMOHERPES | 2004 |
|
RU2258224C1 |
| METHOD FOR TREATING THE CASES OF ULCERATED HERPETIC KERATITIS | 2001 |
|
RU2192898C1 |
| METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 |
|
RU2494741C1 |
| DRUG | 1996 |
|
RU2120294C1 |
| METHOD OF TREATING ULCERATED HERPETIC KERATITIS | 1996 |
|
RU2122844C1 |
| MEDICINAL COMPOSITION FOR TREATMENT OF HERPETIC KERATITIS AND KERATOCONJUNCTIVITIS | 1995 |
|
RU2104002C1 |
| METHOD OF SELECTING THERAPY OF CHRONIC INFLAMMATORY DISEASES OF EYE SURFACE BASED ON CONTROLLED POTENTIATION OF EXUDATIVE REACTION BY MEANS OF MECHANICAL OR IMMUNE IMPACT | 2009 |
|
RU2421193C2 |
| METHOD FOR DETERMINATION OF PRESCRIPTIONS TO CONDUCT COUNTER-HERPETIC THERAPY IN CASE OF CHRONIC CENTRAL BACTERIAL CORNEAL ULCERS | 2016 |
|
RU2623069C1 |
| EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
| PHARMACEUTICAL COMPOSITION ELICITING ANTIVIRAL ACTIVITY AND METHOD OF ITS PREPARING | 2001 |
|
RU2175230C1 |
